The piglet as a model for studying dietary components in infant diets: Effects of galacto-oligosaccharides on intestinal functions

British Journal of Nutrition

Volumn 115, Issue 4, 2016, Pages 605-618

  Alizadeh, A ^a,b   Akbari, P ^a,b   Difilippo, E ^c   Schols, H A ^c   Ulfman, L H ^d   Schoterman, M H C ^b,e   Garssen, J ^a   Fink Gremmels, J ^a   Braber, S ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d FRIESLANDCAMPINA   (Netherlands)

^e DANONE NUTRICIA RESEARCH   (Netherlands)

Author keywords

Galacto oligosaccharides; Gut microbiota; Immunomodulation; Intestinal integrity; Neonatal piglet models

Indexed keywords

ACETIC ACID; ALPHA GLUCOSIDASE; BETA DEFENSIN 2; BUTYRIC ACID; DISACCHARIDASE; GALACTOSE OLIGOSACCHARIDE; LACTASE; LACTIC ACID; LACTOSE; MESSENGER RNA; PROPIONIC ACID; PROTEIN ZO1; SECRETORY IMMUNOGLOBULIN; SUCRASE; VALERIC ACID; BETA DEFENSIN; GALACTOSE; OLIGOSACCHARIDE; PREBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL HEALTH; ANIMAL TISSUE; ARTICLE; ARTIFICIAL MILK; BACTERIAL COUNT; BACTEROIDES; BIFIDOBACTERIUM; BODY WEIGHT; CECUM; CLOSTRIDIA; CONTROLLED STUDY; DIETARY SUPPLEMENT; DUODENUM; ENZYME ACTIVITY; ESCHERICHIA COLI; FECES MICROFLORA; FERMENTATION; GENE EXPRESSION REGULATION; ILEUM; IN VIVO STUDY; INTESTINE FLORA; INTESTINE FUNCTION; JEJUNUM; LACTOBACILLUS; MATURATION; MICROBIAL COLONIZATION; MORPHOMETRICS; NEWBORN; NONHUMAN; PH; PIGLET; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PUERPERIUM; SALIVA LEVEL; STOMACH; UPREGULATION; ANIMAL; ANIMAL FOOD; BIOLOGICAL MODEL; CHEMISTRY; CROSS BREEDING; DIGESTION; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INTESTINE; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY; PIG; SALIVA;

ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; ANIMALS; ANIMALS, NEWBORN; BETA-DEFENSINS; BIFIDOBACTERIUM; CROSSES, GENETIC; DIGESTION; FEMALE; FERMENTATION; GALACTOSE; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOGLOBULIN A, SECRETORY; INTESTINAL MUCOSA; INTESTINES; LACTOBACILLUS; MALE; MODELS, BIOLOGICAL; OLIGOSACCHARIDES; PREBIOTICS; SALIVA; SUS SCROFA;

EID: 84956776076     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114515004997     Document Type: Article

References (73)

1. Martin R, Nauta AJ, Ben Amor K, et al. (2010) Early life: gut microbiota and immune development in infancy. Benef Microbes 1, 367-382.
2. Round JL & Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9, 313-323.
3. Sjgren YM, Jenmalm MC, Bttcher MF, et al. (2009) Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy 39, 518-526.
4. Vael C & Desager K (2009) The importance of the development of the intestinal microbiota in infancy. Curr Opin Pediatr 21, 794-800.
5. Walker A (2010) Breast milk as the gold standard for protective nutrients. J Pediatr 156, S3-S7.
6. Oozeer R, van Limpt K, Ludwig T, et al. (2013) Intestinal microbiology in early life: specific prebiotics can have similar functionalities as human-milk oligosaccharides. Am J Clin Nutr 98, 561S-571S.
7. Arslanoglu S, Moro GE, Schmitt J, et al. (2008) Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr 138, 1091-1095.
8. Jeurink PV, van Esch BC AM, Rijnierse A, et al. (2013) Mechanisms underlying immune effects of dietary oligosaccharides. Am J Clin Nutr 98, 572S-577S.
9. Fanaro S, Marten B, Bagna R, et al. (2009) Galactooligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study. J Pediatr Gastroenterol Nutr 48, 82-88.
10. Silk DB A, Davis A, Vulevic J, et al. (2009) Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 29, 508-518.
11. Barnes JL, Hartmann B, Holst JJ, et al. (2012) Intestinal adaptation is stimulated by partial enteral nutrition supplemented with the prebiotic short-chain fructooligosaccharide in a neonatal intestinal failure piglet model. JPEN J Parenter Enteral Nutr 36, 524-537.
12. Cilieborg MS, Thymann T, Siggers R, et al. (2011) The incidence of necrotizing enterocolitis is increased following probiotic administration to preterm pigs. J Nutr 141, 223-230.
13. Wen K, Tin C, Wang H, et al. (2014) Probiotic Lactobacillus rhamnosus GG enhanced Th1 cellular immunity but did not affect antibody responses in a human gut microbiota transplanted neonatal gnotobiotic pig model. PLOS ONE 9, e94504.
14. Sangild P, Thymann T, Schmidt M, et al. (2014) The preterm pig as a model in pediatric gastroenterology. J Anim Sci 91, 4713-4729.
15. Heinritz SN, Mosenthin R & Weiss E (2013) Use of pigs as a potential model for research into dietary modulation of the human gut microbiota. Nutr Res Rev 26, 191-209.
16. Buddington R & Sangild P (2012) Prenatal gastrointestinal development in the pig and responses after preterm birth. J Anim Sci 90, 290-298.
17. Calder PC, Krauss-etschmann S, De Jong EC, et al. (2006) Early nutrition and immunity - progress and perspectives. Br J Nutr 96, 774-790.
18. Van Hoffen E, Ruiter B, Faber J, et al. (2009) A specific mixture of short-chain galacto-oligosaccharides and long-chain fructooligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy 64, 484-487.
19. Bakker-Zierikzee AM, Alles MS, Knol J, et al. (2007) Effects of infant formula containing a mixture of galacto- and fructooligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Br J Nutr 94, 783-790.
20. Albrecht S, Schols HA, van Zoeren D, et al. (2011) Oligosaccharides in feces of breast- and formula-fed babies. Carbohydr Res 346, 2173-2181.
21. Walton GE, van den Heuvel EGHM, Kosters MHW, et al. (2012) A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age. Br J Nutr 107, 1466-1475.
22. Ritalahti KM, Amos BK, Sung Y, et al. (2006) Quantitative PCR targeting 16S rRNA and reductive dehalogenase genes simultaneously monitors multiple Dehalococcoides strains. Appl Environ Microbiol 72, 2765-2774.
23. Nauta A, van den Heuvel EGHM, Veurink JH, et al. (2008) Bifidobacterium - the invention provides means and methods for detecting, amplifying, quantifying and/or isolating nucleic acid of at least one member of Bifidobacterium. European patent EP 1 997 907.
24. Nauta A, van den Heuvel EGHM, Veurink JH, et al. (2008) Lactobacillus - the invention provides means and methods for detecting, amplifying, quantifying and/or isolating nucleic acid of at least one Lactobacillus organism. European patent EP 1 997 906 A1.
25. Dahlqvist A (1984) Assay of intestinal disaccharidases. Scand J Clin Lab Invest 44, 169-172.
26. Nygard AB, Jrgensen CB, Cirera S, et al. (2007) Selection of reference genes for gene expression studies in pig tissues using SYBR green qPCR. BMC Mol Biol 8, 67.
27. Karlen Y, McNair A, Perseguers S, et al. (2007) Statistical significance of quantitative PCR. BMC Bioinformatics 8, 131.
28. Tzortzis G & Vulevic J (2009) Galacto-oligosaccharide prebiotics. Prebiotics probiotics Sci Technol, 207-244.
29. Palmeira P, Quinello C, Silveira-Lessa AL, et al. (2012) IgG placental transfer in healthy and pathological pregnancies. Clin Exp Immunol 2012, 1-13.
30. Sangild T (2003) Uptake of colostral immunoglobulins by the compromised newborn farm animal. Acta Vet Scand Suppl 98, 105-122.
31. Thompson CL, Wang B & Holmes AJ (2008) The immediate environment during postnatal development has long-term impact on gut community structure in pigs. ISME J 2, 739-748.
32. Swords WE, Wu CC, Champlin FR, et al. (1993) Postnatal changes in selected bacterial groups of the pig colonic microflora. Biol Neonate 63, 191-200.
33. Fanaro S, Chierici R, Guerrini P, et al. (2003) Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 91, 48-55.
34. Sako T, Matsumoto K & Tanaka R (1999) Recent progress on research and applications of non-digestible galacto-oligosaccharides. Int Dairy J 9, 69-80.
35. De Leoz MLA, Wu S, Strum JS, et al. (2013) A quantitative and comprehensive method to analyze human milk oligosaccharide structures in the urine and feces of infants. Anal Bioanal Chem 405, 4089-4105.
36. Jonathan MC, Van Den Borne JJGC, Van Wiechen P, et al. (2012) In vitro fermentation of 12 dietary fibres by faecal inoculum from pigs and humans. Food Chem 133, 889-897.
37. Ladirat SE, Schuren FHJ, Schoterman MHC, et al. (2014) Impact of galacto-oligosaccharides on the gut microbiota composition and metabolic activity upon antibiotic treatment during in vitro fermentation. FEMS Microbiol Ecol 87, 41-51.
38. Bakker-Zierikzee AM, Alles MS, Knol J, et al. (2005) Effects of infant formula containing a mixture of galacto- and fructooligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Br J Nutr 94, 783-790.
39. Holscher HD, Faust KL, Czerkies LA, et al. (2012) Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial. JPEN J Parenter Enteral Nutr 36, 95S-105S.
40. Van Dokkum W, Wezendonk B, Srikumar TS, et al. (1999) Effect of nondigestible oligosaccharides on largebowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr 53, 1-7.
41. Campbell JM, Fahey GC & Wolf BW (1997) Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J Nutr 127, 130-136.
42. Hamer HM, Jonkers D, Venema K, et al. (2008) Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27, 104-119.
43. Dekaney CM, Bazer FW & Jaeger LA (1997) Mucosal morphogenesis and cytodifferentiation in fetal porcine small intestine. Anat Rec 249, 517-523.
44. Pluske JR, Thompson MJ, Atwood CS, et al. (1996) Maintenance of villus height and crypt depth, and enhancement of disaccharide digestion and monosaccharide absorption, in piglets fed on cows whole milk after weaning. Br J Nutr 76, 409-422.
45. Monaco MH, Kashtanov DO, Wang M, et al. (2011) Addition of polydextrose and galactooligosaccharide to formula does not affect bacterial translocation in the neonatal piglet. J Pediatr Gastroenterol Nutr 52, 210-216.
46. Liu P, Piao XS, Kim SW, et al. (2008) Effects of chitooligosaccharide supplementation on the growth performance, nutrient digestibility, intestinal morphology, and fecal shedding of Escherichia coli and Lactobacillus in weaning pigs. J Anim Sci 86, 2609-2618.
47. Jiao LF, Song ZH, Ke YL, et al. (2014) Cello-oligosaccharide influences intestinal microflora, mucosal architecture and nutrient transport in weaned pigs. Anim Feed Sci Technol 195, 85-91.
48. Lalls J-P, Bosi P, Smidt H, et al. (2007) Nutritional management of gut health in pigs around weaning. Proc Nutr Soc 66, 260-268.
49. Walthall K, Cappon GD, Hurtt ME, et al. (2005) Postnatal development of the gastrointestinal system: a species comparison. Birth Defects Res B Dev Reprod Toxicol 74, 132-156.
50. Tsukahara T, Inoue R, Nakatani M, et al. (2015) Influence of weaning age on the villous height and disaccharidase activities in the porcine small intestine. Anim Sci J (epublication ahead of print version 8 July 2015).
51. Buddington RK, Sangild PT, Hance B, et al. (2012) Prenatal gastrointestinal development in the pig and responses after preterm birth. J Anim Sci 90, 290-298.
52. Townley RR (1966) Disaccharidase deficiency in infancy and childhood. Pediatrics 38, 127-141.
53. Lackeyram D, Mine Y, Widowski T, et al. (2012) The in vivo infusion of hydrogen peroxide induces oxidative stress and differentially affects the activities of small intestinal carbohydrate digestive enzymes in the neonatal pig. J Anim Sci 90, 418-420.
54. Macfarlane GT, Steed H & Macfarlane S (2008) Bacterial metabolism and health-related effects of galactooligosaccharides and other prebiotics. J Appl Microbiol 104, 305-344.
55. Suzuki T (2013) Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci 70, 631-659.
56. Odenwald MA & Turner JR (2013) Intestinal permeability defects: is it time to treat? Clin Gastroenterol Hepatol 11, 1075-1083.
57. Wang H, Zhang C, Wu G, et al. (2015) Glutamine enhances tight junction protein expression and modulates corticotropinreleasing factor signaling in the jejunum of weanling piglets. J Nutr 145, 25-31.
58. Skrzypek T, Valverde Piedra JL, Skrzypek H, et al. (2007) Gradual disappearance of vacuolated enterocytes in the small intestine of neonatal piglets. J Physiol Pharmacol 58, 87-95.
59. Beach RC, Menzies IS, Clayden GS, et al. (1982) Gastrointestinal permeability changes in the preterm neonate. Arch Dis Child 57, 141-145.
60. Akbari P, Braber S, Alizadeh A, et al. (2015) Galactooligosaccharides protect the intestinal barrier by maintaining the tight junction network and modulating the inflammatory responses after a challenge with the mycotoxin deoxynivalenol in human Caco-2 cell monolayers and B6C3F1 mice. J Nutr 145, 1604-1613.
61. Peng L, He Z, Chen W, et al. (2007) Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res 61, 37-41.
62. Cani PD, Possemiers S, Van de Wiele T, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091-1103.
63. Kai-Larsen Y, Gudmundsson GH & Agerberth B (2014) A review of the innate immune defence of the human foetus and newborn, with the emphasis on antimicrobial peptides. Acta Paediatr 103, 1000-1008.
64. Schlee M, Harder J, K?ten B, et al. (2008) Probiotic Lactobacilli and VSL#3 induce enterocyte ?-defensin 2. Clin Exp Immunol 151, 528-535.
65. Veldhuizen EJA, Rijnders M, Claassen EA, et al. (2008) Porcine beta-defensin 2 displays broad antimicrobial activity against pathogenic intestinal bacteria. Mol Immunol 45, 386-394.
66. Brandtzaeg P (2007) Induction of secretory immunity and memory at mucosal surfaces. Vaccine 25, 5467-5484.
67. Erickson KL & Hubbard NE (2000) Probiotic immunomodulation in health and disease. J Nutr 130, 403S-409S.
68. Inoue R & Ushida K (2003) Development of the intestinal microbiota in rats and its possible interactions with the evolution of the luminal IgA in the intestine. FEMS Microbiol Ecol 45, 147-153.
69. Inoue R, Tsukahara T, Nakanishi N, et al. (2005) Development of the intestinal microbiota in the piglet. J Gen Appl Microbiol 51, 257-265.
70. Moreau M-C & Gaboriau-Routhiau V (2001) Influence of resident intestinal microflora on the development and functions of the gut-associated lymphoid tissue. Microb Ecol Heal Dis 13, 65-86.
71. Cebra JJ (1999) Influences of microbiota on intestinal immune system development. Am J Clin Nutr 69, 1046S-1051S.
72. Scholtens PAMJ, Alliet P, Raes M, et al. (2008) Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides. J Nutr 138, 1141-1147.
73. Walker WA & Iyengar RS (2015) Breast milk, microbiota, and intestinal immune homeostasis. Pediatr Res 77, 220-228.